首页>投融资
CustomSurg
未透露
CustomSurg是数据驱动的端到端解决方案提供商，旨在加快复杂骨折的手术速度。该公司帮助外科医生选择和实施最佳治疗策略，避免并发症，缩短治疗时间，改善手术效果。
基本信息
-
公司全称CustomSurg AG
-
类型端到端解决方案提供商
-
产业领域医疗器械、治疗设备
-
公司人数15人以下
-
地址Weinbergstrasse 11
-
联系电话
-
邮箱info@customsurg.com
-
成立时间2014-01-01
投融资
-
2024-03-19未公开未透露High-TechGründerfondsCHMBR Partnerskickfund
-
2024-03-19未透露未透露CHMBR PartnersHigh-TechGründerfondskickfund
相关投融资企业
C轮
Francis Medical is a dynamic medical device company committed to developing urological cancer treatments that are tough on cancer yet gentle on patients.In September 2020, Coloplast announced that it has completed a USD 4m (DKK 25m) equity investment in Francis Medical
收并购
Gynesonics is a developer of transcervical, uterus-preserving, incision-free technologies for diagnostic and therapeutic applications (avoiding invasive surgical techniques of hysterectomy or myomectomy for symptomatic uterine fibroids). Products include the Sonata system which combines intrauterine ultrasound guidance with targeted radiofrequency ablation.In April 2023, the company closed a financing round of $25M
未公开
BetaGlue Therapeutics是一家临床分期肿瘤公司，该公司开发了一种先进的放疗平台，能够对不可切除的实体瘤和手术切缘进行局部靶向治疗，称为YntraDose。
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息